Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Sell
43
APYX Quote, Financials, Valuation and Earnings
Last price:
$3.62
Seasonality move
:
3.96%
Day range:
$3.48 - $3.70
52-week range:
$0.76 - $4.44
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.03x
P/B ratio:
23.64x
Volume:
45.4K
Avg. volume:
122.2K
1-year change:
129.94%
Market cap:
$138.2M
Revenue:
$48.1M
EPS (TTM):
-$0.36
Analysts' Opinion
-
Consensus RatingApyx Medical Corp. has received a consensus rating of Buy. The company's average rating is a Buy based on 3 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $6.00, Apyx Medical Corp. has an estimated upside of 66.21% from its current price of $3.61.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $5.00 representing 100% downside risk from its current price of $3.61.
Fair Value
-
According to the consensus of 4 analysts, Apyx Medical Corp. has 66.21% upside to fair value with a price target of $6.00 per share.
APYX vs. S&P 500
-
Over the past 5 trading days, Apyx Medical Corp. has underperformed the S&P 500 by -6.61% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Apyx Medical Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Apyx Medical Corp. has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Apyx Medical Corp. reported revenues of $12.9M.
Earnings Growth
-
Apyx Medical Corp. has grown year-over-year earnings for 4 quarters straight. In the most recent quarter Apyx Medical Corp. reported earnings per share of -$0.05.
Enterprise value:
152.4M
EV / Invested capital:
3.36x
Price / LTM sales:
3.03x
EV / EBIT:
--
EV / Revenue:
3.18x
PEG ratio (5yr expected):
-0.07x
EV / Free cash flow:
-16.03x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$16.2M
Return On Assets:
-24.1%
Net Income Margin (TTM):
-30.32%
Return On Equity:
-146.08%
Return On Invested Capital:
-29.7%
Operating Margin:
-6.46%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $50.3M | $48.5M | $47.9M | $11.5M | $12.9M | |
| Gross Profit | $13.6M | $11.6M | $16.2M | $3.4M | $5.1M | |
| Operating Income | -$20.1M | -$21.6M | -$9.5M | -$3.6M | -$832K | |
| EBITDA | -$19.4M | -$21M | -$8.9M | -$3.5M | -$668K | |
| Diluted EPS | -$0.44 | -$0.82 | -$0.36 | -$0.14 | -$0.05 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $59.9M | $46.3M | $50.2M | $52.2M | $48.8M | |
| Total Assets | $67.8M | $55.3M | $59.4M | $60.7M | $57.4M | |
| Current Liabilities | $11.7M | $11.2M | $10.3M | $9.6M | $11M | |
| Total Liabilities | $13.1M | $13.1M | $25.9M | $49.5M | $51.3M | |
| Total Equity | $54.7M | $42.2M | $33.6M | $11.2M | $6.1M | |
| Total Debt | $270K | $574K | $14.1M | $38.5M | $38.8M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$9.3M | -$15.6M | -$8.4M | -$4.4M | -$3.5M | |
| Cash From Investing | $6.8M | -$570K | -$1M | -$153K | -$519K | |
| Cash From Financing | $9.9M | $22.1M | $6.8M | -$5K | $45K | |
| Free Cash Flow | -$9.9M | -$16.1M | -$9.5M | -$4.6M | -$4.1M | |
APYX
Sector
Market Cap
$138.2M
$28.4M
Price % of 52-Week High
81.42%
51.17%
Dividend Yield
0%
0%
Shareholder Yield
-8.56%
-1.49%
1-Year Price Total Return
129.94%
-16.67%
Beta (5-Year)
1.486
0.518
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$3.73
200-day SMA
Buy
Level
$2.22
Bollinger Bands (100)
Buy
Level
2.08 - 3.7
Chaikin Money Flow
Buy
Level
35M
20-day SMA
Sell
Level
$3.89
Relative Strength Index (RSI14)
Sell
Level
44.04
ADX Line
Sell
Level
15.41
Williams %R
Buy
Level
-81.0127
50-day SMA
Sell
Level
$3.62
MACD (12, 26)
Sell
Level
-0.01
25-day Aroon Oscillator
Buy
Level
8
On Balance Volume
Neutral
Level
42.9M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-0.3439)
Sell
CA Score
(Annual)
Level (-2.3744)
Buy
Beneish M-Score
(Annual)
Level (-2.6869)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (3.9578)
Sell
Piotroski F Score
(Annual)
Level (2)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Apyx Medical Corp. operates as an energy-based medical technology company. The firm engages in developing, manufacturing, and marketing a range of electrosurgical products and technologies, as well as related medical products used by the offices of doctors, surgery centers, and hospitals worldwide. It operates through the following segments: Advanced Energy and Original Equipment Manufacturer (OEM). The company was founded by Andrew Makrides in 1978 and is headquartered in Clearwater, FL.
Stock Forecast FAQ
In the current month, APYX has received 3 Buy ratings 1 Hold ratings, and 0 Sell ratings. The APYX average analyst price target in the past 3 months is $6.00.
-
Where Will Apyx Medical Corp. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Apyx Medical Corp. share price will rise to $6.00 per share over the next 12 months.
-
What Do Analysts Say About Apyx Medical Corp.?
Analysts are divided on their view about Apyx Medical Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Apyx Medical Corp. is a Sell and believe this share price will drop from its current level to $5.00.
-
What Is Apyx Medical Corp.'s Price Target?
The price target for Apyx Medical Corp. over the next 1-year time period is forecast to be $6.00 according to 4 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is APYX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Apyx Medical Corp. is a Buy. 3 of 4 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of APYX?
You can purchase shares of Apyx Medical Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Apyx Medical Corp. shares.
-
What Is The Apyx Medical Corp. Share Price Today?
Apyx Medical Corp. was last trading at $3.62 per share. This represents the most recent stock quote for Apyx Medical Corp.. Yesterday, Apyx Medical Corp. closed at $3.61 per share.
-
How To Buy Apyx Medical Corp. Stock Online?
In order to purchase Apyx Medical Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get APYX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
APYX
Sector
P/E ratio
--
23.89x
PEG ratio
-0.07x
-0.01x
P/B ratio
23.64x
1.81x
Price / LTM sales
3.03x
1.58x
Growth Metrics
APYX
Sector
Revenue growth
12.1%
4.62%
Earnings growth
64.14%
10.7%
Revenue (5-year growth)
11.24%
6.5%
Earnings forecast
-$0.10
-$0.21
Profitability
APYX
Sector
Profitability FY 2024
$12M
$3.6M
Return on invested capital
-29.7%
-31.84%
Return on assets
-24.1%
-27.96%
Return on equity
-146.08%
-37.63%
Earnings Date
Last Earnings Date
Nov
6
Next Earnings Date
Mar
12
Estimated Next Earnings Date
Feb
5
Balance Sheet
APYX
Sector
Total cash
$25.1M
$26.4M
Short term investments
--
$25.7M
Total assets
$64.8M
$76.9M
Long term debt
$38.8M
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 23
Applied Optoelectronics, Inc. [AAOI] is up 3.95% over the past day.
Buy
60
ZBIO alert for Dec 24
Zenas BioPharma, Inc. [ZBIO] is up 1.18% over the past day.
Buy
54
UNF alert for Dec 24
UniFirst Corp. [UNF] is up 0.77% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
